Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

NCT02641158 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

422

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
HIV
AIDS
Substance Use

Interventions

OTHER: Control Group
BEHAVIORAL: Care Facilitation Group

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]